Further analysis is important to evaluate how the above mechanism for the altered gene copy number of wild-type or mutant EGFR gene could be induced during acquisition of drug resistance to EGFR-targeted drugs in lung cancer cells in patients. The gene discussed is EGFR; the disease is lung cancer.